{"disease":{"id":"fatty-liver-disease-nonalcoholic","name":"fatty liver disease nonalcoholic"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04371042","title":"PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT05877547","title":"A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":381,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT03248882","title":"Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":305,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT04321031","title":"Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":256,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT05330923","title":"Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT04801849","title":"Vitamin E Dosing Study","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":true},{"nct_id":"NCT03486899","title":"A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":197,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true},{"nct_id":"NCT03486912","title":"A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":155,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true},{"nct_id":"NCT03915002","title":"Integrated Approaches for Identifying Molecular Targets in Liver Disease","phase":"","overall_status":"COMPLETED","enrollment_count":155,"lead_sponsor_name":"University of Pittsburgh","has_results":false},{"nct_id":"NCT06705868","title":"Chrononutrition/ Chronotoxicity Intervention in People With Metabolic-associated Steatotic Liver Disease.","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Cyprus University of Technology","has_results":false},{"nct_id":"NCT04944992","title":"A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":145,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT06257732","title":"Different Exercise Modalities in the Treatment of NAFLD and Their Impact on Myokines","phase":"NA","overall_status":"UNKNOWN","enrollment_count":144,"lead_sponsor_name":"Yeditepe University","has_results":false},{"nct_id":"NCT06623084","title":"Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":132,"lead_sponsor_name":"Stefania Basili","has_results":false},{"nct_id":"NCT06482112","title":"Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":124,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT03061721","title":"Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":106,"lead_sponsor_name":"Zydus Therapeutics Inc.","has_results":true},{"nct_id":"NCT03572465","title":"Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis","phase":"","overall_status":"RECRUITING","enrollment_count":102,"lead_sponsor_name":"Centre hospitalier de l'Université de Montréal (CHUM)","has_results":false},{"nct_id":"NCT03656744","title":"A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":101,"lead_sponsor_name":"HighTide Biopharma Pty Ltd","has_results":true},{"nct_id":"NCT06739486","title":"Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT05220956","title":"Impact of Time-restricted Feeding in NAFLD","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Johannes Gutenberg University Mainz","has_results":false},{"nct_id":"NCT04165343","title":"Evaluation of Multi-Organ Metabolism and Perfusion in NAFLD by Total Body Dynamic PET Scan on EXPLORER","phase":"","overall_status":"COMPLETED","enrollment_count":81,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT06465186","title":"A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":80,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT02196831","title":"Tesamorelin Effects on Liver Fat and Histology in HIV","phase":"NA","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Massachusetts General Hospital","has_results":true},{"nct_id":"NCT07193927","title":"Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"AB Biotics, SA","has_results":false},{"nct_id":"NCT04710524","title":"FM101 Efficacy Study in Adults With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Future Medicine","has_results":false},{"nct_id":"NCT04783116","title":"Plant Stanols and Liver Inflammation in Overweight and Obese Children","phase":"NA","overall_status":"UNKNOWN","enrollment_count":52,"lead_sponsor_name":"Maastricht University Medical Center","has_results":false},{"nct_id":"NCT04785937","title":"Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Azienda USL Reggio Emilia - IRCCS","has_results":false},{"nct_id":"NCT07321925","title":"Thermoacoustic Method for Estimating Liver Fat Fraction","phase":"","overall_status":"RECRUITING","enrollment_count":49,"lead_sponsor_name":"Endra Lifesciences","has_results":false},{"nct_id":"NCT03683589","title":"De Novo Lipogenesis in Severity of NAFLD","phase":"","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"University of Missouri-Columbia","has_results":false},{"nct_id":"NCT06302049","title":"Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":46,"lead_sponsor_name":"Sadat City University","has_results":false},{"nct_id":"NCT07093346","title":"The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)","phase":"NA","overall_status":"RECRUITING","enrollment_count":45,"lead_sponsor_name":"University of Nottingham","has_results":false},{"nct_id":"NCT02366052","title":"Nutritional Counseling vs. Nutritional Supplements for NASH - a Randomized Prospective, Open Label Pilot Study","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Johannes Gutenberg University Mainz","has_results":false},{"nct_id":"NCT04147195","title":"Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":41,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT03674476","title":"An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Function","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT03445208","title":"A Study of Experimental Medication BMS-986036 Given to Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT01679197","title":"Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"University of Michigan","has_results":true},{"nct_id":"NCT03678727","title":"Effects of Exercise on VLDL-TG Metabolism","phase":"","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT05560607","title":"Knockdown of HSD17B13 mRNA, Pharmacokinetics, Safety, and Tolerability, of AZD7503 in Non-Alcoholic Fatty Liver Disease","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT04175392","title":"Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":14,"lead_sponsor_name":"Corewell Health East","has_results":true},{"nct_id":"NCT06024408","title":"A Trial to Learn if Receiving ALN-PNP siRNA is Safe and Well Tolerated, and How it Works in Adult Participants With Nonalcoholic Fatty Liver Disease (NAFLD) and a Genetic Risk Factor","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT03864835","title":"NASH-FITTER: Nonalcoholic Steatohepatitis Fitness Intervention Treatment Targeting Endothelial Dysfunction Reversal","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Milton S. Hershey Medical Center","has_results":false},{"nct_id":"NCT04109742","title":"Curcumin for Pediatric Nonalcoholic Fatty Liver Disease","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Columbia University","has_results":false}],"total":41},"guidelines":[],"source":"Drug Landscape verified database"}